Cargando…

Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer

BACKGROUND: Glomeruloid microvascular proliferation (GMP), a novel histology-based angiogenesis marker, has been associated with decreased survival in several human cancers. METHODS: In this study, we evaluated the ability of GMP to predict clinical response to neoadjuvant chemotherapy in a series o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akslen, L A, Straume, O, Geisler, S, Sørlie, T, Chi, J-T, Aas, T, Børresen-Dale, A-L, Lønning, P E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137417/ https://www.ncbi.nlm.nih.gov/pubmed/21673677 http://dx.doi.org/10.1038/bjc.2011.203

Ejemplares similares

Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer
por: Goffin, J R, et al.
Publicado: (2003)

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas.
por: Ellis, P. A., et al.
Publicado: (1997)

Glomeruloid Hemangioma in a Patient with TAFRO Syndrome
por: Osano, Keiichi, et al.
Publicado: (2022)

Glomeruloid Hemangioma in Normal Individuals
por: Gupta, Jyoti, et al.
Publicado: (2013)

p16(INK4A) as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy
por: Geisler, S, et al.
Publicado: (2000)

Glomeruloid Structures as Vascular Reaction in Human Gastrointestinal Carcinoma
por: Ohtani, Haruo
Publicado: (1992)

Relation of gene expression-based tumor subclasses to clinical phenotypes
por: Sørlie, T, et al.
Publicado: (2000)

Glomeruloid Hemangioma as a Marker for the Early Diagnosis of POEMS Syndrome
por: Lee, Jin Yong, et al.
Publicado: (2017)

A Case of Oral Glomeruloid Hemangioma Without Systemic Conditions
por: Roy, Rita R, et al.
Publicado: (2022)

Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005)

Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors
por: Flågeng, M Hauglid, et al.
Publicado: (2009)

A familial case of alveolar capillary dysplasia with misalignment of the pulmonary veins: the clinicopathological features and unusual glomeruloid endothelial proliferation
por: Kitano, Akiko, et al.
Publicado: (2020)

Glomeruloid haemangiomas associated with generalized oedema in a patient with atypical POEMS syndrome
por: Kono, Keiji, et al.
Publicado: (2010)

Evaluation of MetriGenix custom 4D™ arrays applied for detection of breast cancer subtypes
por: Muggerud, Aslaug Aamodt, et al.
Publicado: (2006)

Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension
por: Schuster, Cornelia, et al.
Publicado: (2012)

Characterization of extracellular matrix composition in breast carcinoma
por: Bergamaschi, A, et al.
Publicado: (2005)

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response
por: Dejeux, Emelyne, et al.
Publicado: (2010)

Promoter composition predicts gene classes in microarray expression analyses of breast cancer
por: Nordgard, SH, et al.
Publicado: (2005)

Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma
por: Straume, O, et al.
Publicado: (2005)

Lymphatic vessel density and prognosis in cutaneous melanoma
por: Straume, O, et al.
Publicado: (2004)

TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy
por: Eikesdal, Hans P., et al.
Publicado: (2014)

Microvascular proliferation is associated with aggressive tumour features and reduced survival in lung adenocarcinoma
por: Ramnefjell, Maria, et al.
Publicado: (2017)

Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer
por: Helle, S I, et al.
Publicado: (2001)

Predicting response and survival in chemotherapy-treated triple-negative breast cancer
por: Prat, A, et al.
Publicado: (2014)

Is lack of surgery for older breast cancer patients in the UK explained by patient choice or poor health? A prospective cohort study
por: Lavelle, K, et al.
Publicado: (2014)

Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer
por: Aziz, Sura, et al.
Publicado: (2016)

Glomeruloid reactive angioendotheliomatosis in a woman with systemic lupus erythematosus and antiphospholipid syndrome mimicking reticular erythematous mucinosis
por: Ferreli, Caterina, et al.
Publicado: (2020)

Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma
por: Jones, R L, et al.
Publicado: (2006)

Can shear-wave elastography predict response to neoadjuvant chemotherapy in women with invasive breast cancer?
por: Evans, A, et al.
Publicado: (2013)

Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer
por: Woolf, D K, et al.
Publicado: (2014)

Risk for contralateral breast cancer among carriers of the CHEK2(*)1100delC mutation in the WECARE Study
por: Mellemkjær, L, et al.
Publicado: (2008)

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
por: Ladstein, Rita G, et al.
Publicado: (2010)

Lack of clinical efficacy of imatinib in metastatic melanoma
por: Ugurel, S, et al.
Publicado: (2005)

Subclassification and molecular characterization of early stage breast carcinomas using Applied Biosystems Human Genome Survey Microarrays
por: Wang, Y, et al.
Publicado: (2005)

A Case of Follicular Tumor of Uncertain Malignant Potential (FT-UMP) with Glomeruloid Features Showing Capsular Mucinous Degeneration
por: Cabibi, Daniela, et al.
Publicado: (2021)

Screening breast cancer patients for Norwegian ATM mutations
por: Laake, K, et al.
Publicado: (2000)

Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study
por: Conte, P F, et al.
Publicado: (2005)

HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients
por: Del Mastro, L, et al.
Publicado: (2005)

Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers
por: Berge, Elisabet Ognedal, et al.
Publicado: (2010)

Diabetic Peripheral Microvascular Complications: Relationship to Cognitive Function
por: Ba-Tin, Lorraine, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_k5ma2ti50340413l5d54dotb8q